Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
Vaxart Announces the Publication of Studies in the Peer-Reviewed Journal Science Translational Medicine That Suggest Mucosal Immunization Could Decrease SARS-CoV-2 Transmission
12:30pm, Thursday, 19'th May 2022 GlobeNewswire Inc.
A preclinical study in hamsters showed both a decrease in infectious virus and in transmission
These 3 Former High-Flying Stocks Can Soar Up to 439%, According to Wall Street
09:51am, Wednesday, 18'th May 2022 The Motley Fool
Select analysts foresee these once-popular stocks delivering huge gains for shareholders.
These 3 Former High-Flying Stocks Can Soar Up to 439%, According to Wall Street
05:51am, Wednesday, 18'th May 2022
Select analysts foresee these once-popular stocks delivering huge gains for shareholders.
Can This 1 Thing Hurt Vaxart?
10:00am, Monday, 16'th May 2022 The Motley Fool
The company still is far from the vaccine race finish line.
Can This 1 Thing Hurt Vaxart?
06:00am, Monday, 16'th May 2022
The company still is far from the vaccine race finish line.
Vaxart Provides Business Update and Reports First Quarter 2022 Financial Results
09:46pm, Monday, 09'th May 2022 GlobeNewswire Inc.
Data from COVID-19 Phase II study and norovirus Phase IB study are expected in 2022
Thinking of Buying BioNTech? Consider These 3 Things First
02:45pm, Friday, 29'th Apr 2022 The Motley Fool
There's trouble ahead, but a few new solutions are on the way too.
3 Stocks That Have Analysts Running for the Exit
06:30am, Wednesday, 27'th Apr 2022
Here are three stocks that have analysts running for the exit due to their declining or risky market prospects The post 3 Stocks That Have Analysts Running for the Exit appeared first on InvestorPlace
2 Contenders in the Coronavirus Vaccine Market -- Are They Buys?
03:30pm, Monday, 25'th Apr 2022 The Motley Fool
These two companies have been left in the dust. Is it too late for them?
3 Biotech Stocks That Could Help Make You a Fortune
10:00am, Thursday, 14'th Apr 2022 The Motley Fool
Their products could deliver major revenue over time.
3 of the Fastest-Growing Stocks on the Planet Through 2026
09:51am, Thursday, 07'th Apr 2022 The Motley Fool
These stocks are expected to grow their sales by 26,519% to 100,236% over the next five years.
3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall Street
09:21am, Wednesday, 06'th Apr 2022 The Motley Fool
Select analysts foresee these coronavirus stocks rocketing higher by 246% to 355% over the next year.
Make Biotech Cash Considerations With SBIO
08:59pm, Monday, 28'th Mar 2022
In financial markets, it's often said that cash is king. That's something to remember when it comes to the biotechnology universe due to the cost-intensive nature of developing new drugs and therapies
Is Vaxart the Next Moderna?
03:15pm, Saturday, 26'th Mar 2022 The Motley Fool
The similarities are striking.
Is Vaxart the Next Moderna?
11:15am, Saturday, 26'th Mar 2022
The similarities are striking.
